Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of inhaled bromhexine hydrochloride for mucus symptoms in adult lower respiratory infections
ChiCTR2500097308Phase 3Recruiting
- Sponsor
- Shenzhen People's Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bromhexine in pulmonary infection, chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD) and 3 more (2 arms), sponsored by Shenzhen People's Hospital. Primary endpoint: Change from baseline in sputum trait score after completion of treatment. Started Feb 2025; status: recruiting.
02
Drugs
bromhexine
03
Conditions
pulmonary infectionchronic bronchitis (CB)chronic obstructive pulmonary disease (COPD)bronchiectasispneumonia
Beyond the preview
Go deeper on ChiCTR2500097308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097308.